Indra Scheen is a seasoned project manager and consultant at Progress since March 2018, specializing in quality assurance and various technical roles within the life sciences sector, notably in vaccine development for influenza and Covid-19. Prior to this, Indra served as the Intercompany Employee Health Lead for Johnson & Johnson in the Netherlands, where responsibilities included the launch and management of global health initiatives. Indra has held prominent leadership positions at The Janssen Pharmaceutical Companies, overseeing manufacturing and quality control teams. With a background in research from institutions such as Harvard University and Leiden University Medical Center, along with entrepreneurial experience as the owner of STUDIO INDRA, Indra's education includes a Lean Six Sigma Green Belt certificate and a Bachelor of Applied Science in Biochemistry from Hogeschool INHolland.